Summary
- Current Price
- As of today, NRIX price is $23.82, up +0.61% in the most recent trading session on
- Current Price All-Time High
- NRIX price is currently -54.52% below its historical high of $52.38 set on
- Market Cap
- NRIX current market cap is $2B, up +248.03% over the past 365 days
- Revenue
- NRIX current annual revenue is $83.98M, up +53.95% year-over-year
- Next Earnings
- The next earnings release for NRIX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Nurix Therapeutics, Inc. |
| Ticker | NASDAQ: NRIX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | nurixtx.com |
| Employees | 286 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $23.82 | |
| Price, 1D Change | +0.61% | |
| $2B | ||
| - | ||
| - | ||
| 1.42 | ||
| $83.98M | ||
| Revenue, 1Y Change | +53.95% | |
| -$3.05 | ||
| EPS, 1Y Change | -5.81% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$3.05 | ||
| EPS Estimate | $3.38 | N/A |
| EPS Est. Change | +210.64% | N/A |
| $83.98M | ||
| Revenue Estimate | $755.34M | N/A |
| Revenue Est. Change | +799.42% | N/A |
| Current Price | $23.82 | |
| Price Target | $34.00 | - |
| Price Tgt. Change | +42.74% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.77 | -$2.88 | -4.13% | |
| -$3.10 | -$3.05 | +1.55% | |
| $3.38 | N/A | +210.64% | |
| -$1.07 | N/A | +65.09% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $54.66M | $54.55M | -0.20% | |
| $85.23M | $83.98M | -1.46% | |
| $755.34M | N/A | +799.42% | |
| $120.76M | N/A | +43.80% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $23.82 | |
| $19.52 | ||
| $25.30 | ||
| $20.23 | ||
| $24.55 | ||
| -$0.51 | ||
| 1.42 | ||
| $1.03 | ||
| 38.87 | ||
| 43.59% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $83.98M | ||
| -$3.05 | ||
| $65.12M | ||
| 77.55% | ||
| -$285.67M | ||
| -340.16% | ||
| -$264.46M | ||
| -314.90% | ||
| -$266.81M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.10 | ||
| 7.02 | ||
| 7.02 | ||
| - | ||
| 1 | ||
| 6.72 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 67.24 | ||
| 6.14 | ||
| -6.07 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $538.75M | ||
| $592.94M | ||
| $702.56M | ||
| $606.82M | ||
| $163.82M | ||
| $86.47M | ||
| $55.73M | ||
| $2.82M | ||
| $11.22M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $348.44M | ||
| $350.79M | ||
| $18.86M | ||
| $0.00 | ||
| $18.86M | ||
| $0.00 | ||
| $760.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$249.47M | ||
| $147.85M | ||
| $238.64M | ||
| $14.00M | ||
| -$263.47M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| RBC Capital | → | |
| Needham | → | |
| Morgan Stanley | → | |
| UBS | → | |
| Mizuho | → | |
| Truist Securities | → | |
| Stifel | → | |
| RBC Capital | → | |
| Needham | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
No data
Screeners with NRIX
FAQ
- What is the ticker symbol for Nurix Therapeutics, Inc.?
- The ticker symbol for Nurix Therapeutics, Inc. is NASDAQ:NRIX
- Does Nurix Therapeutics, Inc. pay dividends?
- No, Nurix Therapeutics, Inc. does not pay dividends
- What sector is Nurix Therapeutics, Inc. in?
- Nurix Therapeutics, Inc. is in the Healthcare sector
- What industry is Nurix Therapeutics, Inc. in?
- Nurix Therapeutics, Inc. is in the Biotechnology industry
- What country is Nurix Therapeutics, Inc. based in?
- Nurix Therapeutics, Inc. is headquartered in United States
- When did Nurix Therapeutics, Inc. go public?
- Nurix Therapeutics, Inc. initial public offering (IPO) was on July 24, 2020
- Is Nurix Therapeutics, Inc. in the S&P 500?
- No, Nurix Therapeutics, Inc. is not included in the S&P 500 index
- Is Nurix Therapeutics, Inc. in the NASDAQ 100?
- No, Nurix Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Nurix Therapeutics, Inc. in the Dow Jones?
- No, Nurix Therapeutics, Inc. is not included in the Dow Jones index
- When was Nurix Therapeutics, Inc. last earnings report?
- Nurix Therapeutics, Inc.'s most recent earnings report was on July 9, 2026
- When does Nurix Therapeutics, Inc. report earnings?
- The next expected earnings date for Nurix Therapeutics, Inc. is October 8, 2026
Data Sources & References
- NRIX Official Website www.nurixtx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1549595/000154959526000016/0001549595-26-000016-index.htm
- NRIX Profile on Yahoo Finance finance.yahoo.com/quote/NRIX
- NRIX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nrix